MOLECULAR PARTNERS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.35 CHF | -1.47% |
|
+5.18% | -2.62% |
Chart calendar Molecular Partners AG
16fd7a99225e23c69c987db3e687.O-kM0_gWW_ZpSvVfLjNhoxSQkUX_lNTpGm8_sIH6uf4.dr9jlY9hCaUoG4E0dncT5HHK4Ce87YKlWQZenfeu_8p4n2iatEYctzZ9oA~0abaf04351a885aa06562a090a6aba40
Upcoming events on Molecular Partners AG
Past events on Molecular Partners AG
| 2024-04-17 03:00 am | Annual General Meeting |
| 2024-03-15 08:00 am | Q4 2023 Earnings Call |
| 2024-03-14 04:00 pm | Q4 2023 Earnings Release |
| 2024-03-10 | Leerink Partners Global Biopharma Conference |
| 2024-03-06 10:30 am | TD Cowen Health Care Conference - Fireside Chat |
| 2024-03-05 09:10 am | TD Cowen Health Care Conference - Panel |
| 2024-01-10 | Octavian Seminar |
| 2024-01-10 01:30 pm | JPMorgan Healthcare Conference |
| 2024-01-10 10:30 am | Baader Swiss Equities Conference |
| 2024-01-06 | Investor Meeting |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Poster Number : 2921 |
| 2023-11-15 08:00 am | UBS Swiss Equity Technology and Innovation Day |
| 2023-11-14 06:15 am | Protein & Antibody Engineering European Summit |
| 2023-11-03 09:00 am | TD Cowen Fall Oncology Innovation Summit |
| 2023-11-02 | Society for Immunotherapy of Cancer Meeting - Abstract Number 721 |
| 2023-10-25 | Q3 2023 Sales and Revenue Release - Interim Management Statement |
| 2023-09-13 04:05 am | European Association of Nuclear Medicine Meeting - Abstract No : OP-897 |
| 2023-08-25 08:00 am | Q2 2023 Earnings Call |
| 2023-08-24 04:00 pm | Q2 2023 Earnings Release |
| 2023-06-20 12:00 pm | TD Cowen Radiopharmaceutical Innovation Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 20,4 28,3 -27.99% | 9,30 31,6 -70.61% | 9,75 14,9 -34.51% | 190 184 3.29% | 7,00 4,49 55.96% | 13,9 |
|
EBITDA Million CHF | Released Forecast Spread | -34,2 -30,9 -10.65% | -55,4 -31,3 -77.32% | -60,9 -56,3 -8% | 119 112 6.18% | -58,7 -59,2 0.81% | -54,0 |
|
EBIT Million CHF | Released Forecast Spread | -37,2 -35,7 -4.07% | -58,3 -34,1 -70.88% | -63,4 -56,7 -11.78% | 117 105 10.66% | -61,1 -70,7 13.55% | -63,2 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -36,8 -35,8 -2.67% | -62,8 -31,5 -99.06% | -63,8 -54,8 -16.43% | 118 110 7.58% | -62,0 -70,5 12.08% | -65,7 |
|
Net income Million CHF | Released Forecast Spread | -36,8 -34,6 -6.34% | -62,8 -34,2 -83.5% | -63,8 -58,2 -9.65% | 118 113 4.42% | -62,0 -67,8 8.51% | -59,7 |
|
EPS CHF | Released Forecast Spread | -1,72 -1,57 -9.74% | -2,51 -1,30 -93.27% | -2,06 -2,01 -2.33% | 3,54 3,34 5.97% | -1,89 -1,99 5.24% | -1,70 |
| Announcement Date | 06/02/20 | 05/02/21 | 15/03/22 | 09/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 7,52 9,00 -16.49% | 1,78 20,0 -91.08% | 4,40 2,99 47.23% | 5,34 10,0 -46.63% | 185 183 0.82% | 5,10 4,40 15.91% | 3,50 4,05 -13.58% | 3,50 3,60 -2.78% | 1,30 |
|
EBIT Million CHF | Released Forecast Spread | -23,1 -23,3 0.89% | -35,2 -11,2 -214.26% | -34,8 -32,6 -6.88% | ||||||
|
Net income Million CHF | Released Forecast Spread | -24,7 -23,0 -7.6% | -38,1 -10,8 -252.65% | -33,6 -30,8 -9.13% | -30,2 -33,6 10.07% | 149 139 6.68% | -30,8 -29,3 -5.14% | -30,8 -28,3 -8.83% | -31,2 -31,9 2.13% | |
|
EPS CHF | Released Forecast Spread | -1,14 -1,06 -7.55% | -1,37 -0,38 -260.53% | -1,13 -1,16 2.16% | -0,93 -1,68 44.64% | |||||
| Announcement Date | 26/08/20 | 05/02/21 | 26/08/21 | 15/03/22 | 25/08/22 | 09/03/23 | 24/08/23 | 14/03/24 | - |
More events
Past sector events for Molecular Partners AG
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MOLN Stock
- Calendar Molecular Partners AG